Impact of HCV Treatment on Recurrence of Hepatocarcinoma After Liver Transplantation

被引：1
|
作者：
Burgos, Maria Martinez [1 ]
Grande, Rocio Gonzalez [1 ]
Ortega, Susana Lopez [1 ]
Leiva, Inmaculada Santaella [1 ]
De La Cruz Lombardo, Jesus [1 ]
Santoyo, Julio Santoyo [2 ]
Perez, Miguel Jimenez [1 ]
机构：
[1] Reg Univ Hosp Malaga, Digest Syst Clin Management Unit, Malaga 29010, Spain
[2] Reg Univ Hosp Malaga, Hepatobiliary Surg Clin Management Unit, Malaga, Spain
来源：
TRANSPLANTATION PROCEEDINGS | 2023年 / 55卷 / 01期
关键词：
D O I：
10.1016/j.transproceed.2022.12.011
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The treatment of hepatitis C virus (HCV) has been a revolution in hepatology. Since the begin-ning of transplantation, liver cirrhosis and hepatocarcinoma on HCV cirrhosis has been the main etiology of liver transplantation. We set out to analyze the impact that C virus treatment has had on liver transplantation. To do so, we divided our cohort into 2 periods, one before virus treat-ment (from 2000-2014) and one after the onset of treatment (2014-2020). Taling into account this differentiation, we analyzed the percentage of patients transplanted for hepatocarcinoma over cirrhotic liver by HCV in both groups. Among the patients transplanted for HCV, we ana-lyzed whether there were differences in hepatocarcinoma recurrences according to their serologic status at the time of transplantation.
引用
收藏
页码：197 / 198
页数：2
相关论文
共 50 条
  • [1] Impact of sirolimus on HCV recurrence rates after liver transplantation
    Asthana, Sonal
    Toso, Christian
    Meeberg, Glenda
    Kawahara, Toshiyasu
    Bigam, David
    Shapiro, A. J.
    Mason, Andrew
    Kneteman, Norman
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 306 - 306
  • [2] Impact of Rapamycin on HCV Recurrence after Liver Transplantation.
    Johnson, M.
    Sellers, M.
    Bruno, C.
    Kegley, K.
    Tan, M.
    Pollinger, H.
    Galambos, M.
    Cross, R.
    Jones, J.
    Sutton, P.
    Rubin, R.
    Shrestha, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 528 - 528
  • [3] ANTIVIRAL TREATMENT OF HCV RECURRENCE AFTER LIVER TRANSPLANTATION: IMPACT ON COSTS AND QUALITY OF LIFE
    Logge, Christoph
    Vettorazzi, Eik
    Nashan, Bjoern
    Sterneck, Martina R.
    HEPATOLOGY, 2010, 52 (04) : 759A - 759A
  • [4] ANTIVIRAL TREATMENT OF HCV RECURRENCE AFTER LIVER TRANSPLANTATION: IMPACT ON COSTS AND QUALITY OF LIFE
    Logge, C.
    Vettorazzi, E.
    Nashan, B.
    Sterneck, M.
    TRANSPLANT INTERNATIONAL, 2010, 23 : 57 - 58
  • [5] HCV recurrence after liver transplantation
    Nature Clinical Practice Gastroenterology & Hepatology, 2004, 1 (2): : 66 - 66
  • [6] Timing for treatment of HCV recurrence after liver transplantation: the earlier the better
    Russo, Francesco Paolo
    Zanetto, Alberto
    Burra, Patrizia
    TRANSPLANT INTERNATIONAL, 2016, 29 (06) : 694 - 697
  • [7] Immunosuppression and HCV recurrence after liver transplantation
    Samonakis, Dimitrios N.
    Germani, Giacomo
    Burroughs, Andrew K.
    JOURNAL OF HEPATOLOGY, 2012, 56 (04) : 973 - 983
  • [8] IMPACT OF HCV TREATMENT ON RENAL FUNCTION AFTER LIVER TRANSPLANTATION
    Huard, Genevieve
    Bilodeau, Marc
    HEPATOLOGY, 2011, 54 : 622A - 622A
  • [9] Antiviral treatment in HCV recurrence after liver transplantation in HCV-HIV coinfected patients
    Castells, LL
    Vargas, V
    Len, O
    Bilbao, I
    Margarit, C
    Pahissa, A
    Esteban, JI
    Esteban, R
    Guardia, J
    LIVER TRANSPLANTATION, 2005, 11 (07) : C77 - C77
  • [10] ANTIVIRAL TREATMENT (AT) FOR HCV RECURRENCE FOLLOWING LIVER TRANSPLANTATION: THE IMPACT ON FIBROSIS PROGRESSION
    De Martin, Eleonora
    Senzolo, Marco
    Ponziani, Francesca R.
    Vigano, Raffaella
    Belli, Luca
    Pinzello, Giovambattista
    Colledan, Michele
    Donato, Francesca
    Di Paolo, Daniele
    Angelico, Mario
    Rendina, Maria
    Pompili, Maurizio
    Gasbarrini, Antonio
    Russo, Francesco P.
    Cillo, Umberto
    Fagiuoli, Stefano
    TRANSPLANT INTERNATIONAL, 2009, 22 : 28 - 28
12345